News IntegraGen

Equities

ALINT

FR0010908723

Market Closed - Euronext Paris Other stock markets 09:05:14 26/04/2024 pm IST			5-day change	1st Jan Change
0.59 ^EUR	-1.67%		-9.23%	-34.00%

2023	IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2023	CI
2023	IntegraGen SA Announces Revenue Results for the First Half of 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

IntegraGen: Annual Results 2023 - Positive EBITDA Reflecting Tight Cost Control	18/04	BU
IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2023	23/23/23	CI
IntegraGen SA Announces Revenue Results for the First Half of 2023	13/23/13	CI
IntegraGen : reports 2022 annual results with a growth of 16% in revenues and a positive EBITDA.	24/23/24	PU
IntegraGen : Inside Information / Information on annual revenues	13/23/13	PU
IntegraGen Announces Unaudited Revenue Results for the Full Year 2022	13/23/13	CI
IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2022	18/22/18	CI
IntegraGen SA Reports Earnings Results for the Half Year Ended September 30, 2022	18/22/18	CI
IntegraGen SA Reports Earnings Results for the Half Year Ended September 30, 2022	18/22/18	CI
IntegraGen : reports 6.4 M€ in revenues for the first half of 2022 representing 34% growth compared to H1 2021. Cash position of 4.5 M€.	13/22/13	PU
IntegraGen : reports 2021 annual results with a strong growth of 20% in revenue from current operations and a significant profitability improvement	29/22/29	PU
IntegraGen SA Reports Earnings Results for the Full Year Ended December 31, 2021	29/22/29	CI
2021 revenue: €10.9 million, a strong growth by +21% compared to 2020, and cash position of €4.8 million	14/22/14	PU
IntegraGen SA Announces Earnings Result for the First Half of 2021	08/21/08	CI
Global markets live: Intel, Moderna, Burberry, Pfizer, SoftwareOne, Swisscom...	16/21/16
IntegraGen SA Announces Unaudited Turnover for the First Half of 2021	16/21/16	CI
Integragen Sa Reports Earnings Results for the Full Year Ended December 31, 2020	20/21/20	CI
IntegraGen reports 2020 annual results: 10% growth in revenue from current operations and achievement of breakeven operating profits	19/21/19	PU
IntegraGen : reports 2020 revenue of €9.0 million, an increase of +10%, and a cash position of €5.0 million as of December 31, 2020	12/21/12	PU
OncoDNA SA completed the acquisition of 64.7% stake in IntegraGen SA for €9.4 million.	12/20/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News IntegraGen

Equities

ALINT

FR0010908723

Summary

Filters